Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation
- PMID: 29732918
- DOI: 10.1080/13557858.2018.1471669
Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation
Abstract
Objective: Florida has one of the highest cervical cancer mortality rates and socioeconomically diverse populations in the United States. We used statewide population-based cancer registry data to assess disparities in cervical cancer stage at diagnosis. Design: Primary invasive adult female cervical cancer patients in the Florida Cancer Data Registry (1981-2013) were linked with 2000 United States Census data. Early (localized) and advanced (regional and distant) stage at diagnosis was assessed by age, race, ethnicity, neighborhood socioeconomic-, marital-, and smoking- status. Univariate and multivariable logistic regression models were fit to identify factors associated with the risk of advanced cervical cancer stage at diagnosis. Adjusted odds ratios (aOR) and corresponding 95% confidence intervals (95%CI) were calculated. Results: Of 18,279 women (meanage 51.3 years old), most were non-Hispanic (83.5%), white (79.1%), middle-low neighborhood socioeconomic status (NSES) (34.7%), married (46.0%), and never smoked (56.0%). Higher odds of advanced stage was observed for blacks (aOR: 1.42, 95%CI: 1.30-1.55, p < 0.001) compared to whites, Hispanics (1.15, 1.06-1.25, p = 0.001) compared to non-Hispanics, and middle-low (1.13, 1.02-1.25, p = 0.02) and low NSES (1.42, 1.28-1.57, p < 0.001) compared to high NSES. Previously (1.30, 1.21-1.39, p < 0.001) and never married (1.37, 1.27-1.48, p < 0.001) had higher odds of presenting with advanced stage versus married women. Never smokers had decreased odds of presenting with advanced stage compared to women with history of (1.41, 1.32-1.52, p < 0.001) or current (1.29, 1.18-1.42, p < 0.001)smoking status. Conclusions: There are cancer disparities in women of black race, Hispanic ethnicity and of middle-low and lowest NSES in Florida. Evidence-based interventions targeting these vulnerable groups are needed. Abbreviations: HPV: Human Papilloma Virus; CDC: Center for Disease Control and Prevention; SES: socioeconomic status; FCDS: Florida Cancer Data System; NSES: Neighborhood Socioeconomic Status; NPCR: National Program of Cancer Registries; IRB: Institutional Review Board; ACS: American Community Survey; SEER: Surveillance, Epidemiology and End Results; OR: Odds Ratio; CI: Confidence Interval.
Keywords: Cervical cancer; Florida; cancer stage; disparities; ethnicity; race.
Similar articles
-
Geographic variations of racial/ethnic disparities in cervical cancer mortality in Texas.South Med J. 2014 May;107(5):281-8. doi: 10.1097/SMJ.0000000000000100. South Med J. 2014. PMID: 24937725
-
Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.Milbank Q. 2018 Dec;96(4):706-754. doi: 10.1111/1468-0009.12355. Milbank Q. 2018. PMID: 30537364 Free PMC article.
-
Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.Clin Orthop Relat Res. 2018 Dec;476(12):2301-2308. doi: 10.1097/CORR.0000000000000511. Clin Orthop Relat Res. 2018. PMID: 30303879 Free PMC article.
-
The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.J Womens Health (Larchmt). 2009 Jun;18(6):883-93. doi: 10.1089/jwh.2008.1127. J Womens Health (Larchmt). 2009. PMID: 19514831 Review.
-
Risk factors for invasive cervical cancer in Latino women.J Med Syst. 1996 Oct;20(5):277-93. doi: 10.1007/BF02257041. J Med Syst. 1996. PMID: 9001995 Review.
Cited by
-
Sociodemographic characteristics and their association with survival in women with cervical cancer.BMC Cancer. 2024 Feb 1;24(1):161. doi: 10.1186/s12885-024-11909-3. BMC Cancer. 2024. PMID: 38302893 Free PMC article.
-
SFN Enhanced the Radiosensitivity of Cervical Cancer Cells via Activating LATS2 and Blocking Rad51/MDC1 Recruitment to DNA Damage Site.Cancers (Basel). 2022 Apr 8;14(8):1872. doi: 10.3390/cancers14081872. Cancers (Basel). 2022. PMID: 35454780 Free PMC article.
-
Factors Associated with Duration of Overall Treatment Time for Cervical Cancer Treated with Definitive Chemoradiotherapy.Cureus. 2019 Oct 21;11(10):e5951. doi: 10.7759/cureus.5951. Cureus. 2019. PMID: 31799092 Free PMC article.
-
LncRNA FAM13A-AS1 Regulates Proliferation and Apoptosis of Cervical Cancer Cells by Targeting miRNA-205-3p/DDI2 Axis.J Oncol. 2022 Jun 23;2022:8411919. doi: 10.1155/2022/8411919. eCollection 2022. J Oncol. 2022. PMID: 35783157 Free PMC article.
-
Racial/Ethnic Disparities in Cervical Cancer Stage at Diagnosis: Mediating Effects of Neighborhood-level Socioeconomic Deprivation.Cancer Epidemiol Biomarkers Prev. 2023 Jun 1;32(6):818-824. doi: 10.1158/1055-9965.EPI-23-0038. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37067295 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical